Evidence map›Paper›PMID 37176754›Full record

ArticleJournal of clinical medicine2023

Ventilatory Effects of Isoflurane Sedation via the Sedaconda ACD-S versus ACD-L: A Substudy of a Randomized Trial.

Lukas M Müller-Wirtz, Tobias Becher, Ulf Günther, Martin Bellgardt, Peter Sackey, Thomas Volk, Andreas Meiser

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. [S1 guideline on sustainability in intensive care and emergency medicine].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Lukas M Müller-WirtzDepartment of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany.ORCID 0000-0002-7984-1798
Tobias BecherDepartment of Anesthesiology and Intensive Care Medicine, Campus Kiel, University Medical Center Schleswig-Holstein, 24118 Kiel, Germany.ORCID 0000-0003-2026-7629
Ulf GüntherDepartment of Anaesthesiology, Intensive Care, Emergency Medicine, Pain Therapy, University Hospital Oldenburg, 26133 Oldenburg, Germany.
Martin BellgardtDepartment of Anaesthesiology and Intensive Care Medicine, St. Josef-Hospital, University Hospital of the Ruhr-University Bochum, 44780 Bochum, Germany.
Peter SackeyUnit of Anesthesiology and Intensive Care, Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden.
Thomas VolkDepartment of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany.ORCID 0000-0001-5175-7159
Andreas MeiserDepartment of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, 66421 Homburg, Germany.ORCID 0000-0001-6569-7003
Outcomes Research Consortium · USChristian-Albrechts-Universität zu Kiel · DEKarolinska Institutet · SEKlinikum Oldenburg · DESaarland University · DESt. Josef-Hospital · DE

Funding

Sedana Medical none
6 · The paper itself

Abstract

Devices used to deliver inhaled sedation increase dead space ventilation. We therefore compared ventilatory effects among isoflurane sedation via the Sedaconda ACD-S (internal volume: 50 mL), isoflurane sedation via the Sedaconda ACD-L (100 mL), and propofol sedation with standard mechanical ventilation with heat and moisture exchangers (HME). This is a substudy of a randomized trial that compared inhaled isoflurane sedation via the ACD-S or ACD-L to intravenous propofol sedation in 301 intensive care patients. Data from the first 24 h after study inclusion were analyzed using linear mixed models. Primary outcome was minute ventilation. Secondary outcomes were tidal volume, respiratory rate, arterial carbon dioxide pressure, and isoflurane consumption. In total, 151 patients were randomized to propofol and 150 to isoflurane sedation; 64 patients received isoflurane via the ACD-S and 86 patients via the ACD-L. While use of the ACD-L was associated with higher minute ventilation (average difference (95% confidence interval): 1.3 (0.7, 1.8) L/min,

Indexed as

anesthesiacritical careintensive careisofluranepropofolsedationvolatile anesthetic

Identifiers

PMID37176754
PMCPMC10179426
OpenAlexW4376631252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.